Board Meeting6 Nov 2026, 04:19 pm
ANG Lifesciences Board Meeting on Nov 14 to Approve Financial Results
AI Summary
ANG Lifesciences India Ltd has announced a Board of Directors meeting scheduled for November 14, 2026. The primary agenda is to consider and approve the standalone and consolidated un-audited financial results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window will be closed from October 1, 2026, until 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To approve un-audited financial results for Q2 FY27.
- Both standalone and consolidated results will be reviewed.
- Trading window closure announced from October 1, 2026.
Price Impact
More from ANG